We didn’t just make it up. The November strategy was specifically developed to enable accelerated approval to be a serious possibility. Ultimately any decision around approval will be up to the FDA, all we can do is provide them with compelling data that allows them to make such a decision.
The FDA really does wants to see good drugs get to patients as quickly as possible - it is the job of companies like Race to give them the high quality data that allows them to approve your drug.
We didn’t just make it up. The November strategy was...
-
- There are more pages in this discussion • 899 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.82 |
Change
-0.005(0.27%) |
Mkt cap ! $309.9M | |||
| Open | High | Low | Value | Volume |
| $1.83 | $1.86 | $1.79 | $157.7K | 86.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5623 | $1.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 9999 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |